Deep Margin podcast

Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium

31.5.2026
0:00
39:56
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.

Flere episoder fra "Deep Margin"